LCT Insider Trading (Living Cell Technologies)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$140,000.00
Insider Selling (Last 12 Months): A$0.00
Living Cell Technologies Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
Living Cell Technologies Insider Trading History
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|7/1/2021||Kenneth (Ken) Taylor||Insider||Expiry||350,000||A$0.01||A$4,550.00|
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
SEC Filings (Institutional Ownership Changes) for Living Cell Technologies (ASX:LCT)
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
50 Day Range
52 Week Range
Who are the company insiders with the largest holdings of Living Cell Technologies?